CAL
HQL

Capital Analysts LLC’s abrdn Life Sciences Investors HQL Stock Holding History

Capital Analysts LLC’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,000
Closed -$113K – 367
2015
Q2 		$113K Buy
4,000
+2,000
+100% +$55.4K 0.02% 202
2015
Q1 		$55.1K Hold
2,000
– – 0.01% 265
2014
Q4 		$49.8K Buy
+2,000
New +$48K 0.01% 255

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Capital Analysts LLC's HQL Position: Q3 2015 in Review

Capital Analysts LLC sold out of abrdn Life Sciences Investors (HQL) in Q3 2015, closing a stake of 4,000 shares — an estimated $113K sold.

Capital Analysts LLC first reported a position in HQL in Q4 2014 and held it in 3 quarters. The position peaked at $113K in Q2 2015. 48 funds tracked by Wall St. Rank hold HQL as of Q3 2015.

  • Capital Analysts LLC reported no remaining abrdn Life Sciences Investors position as of Q3 2015 after selling out during the quarter.
  • Capital Analysts LLC sold 4,000 abrdn Life Sciences Investors shares in Q3 2015, an estimated $113K.
  • Capital Analysts LLC first reported a position in abrdn Life Sciences Investors in Q4 2014 and held it in 3 quarters.
  • Capital Analysts LLC's abrdn Life Sciences Investors position peaked at $113K in Q2 2015.
  • 48 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2015.

Based on Capital Analysts LLC's 13F filing for Q3 2015, filed 13 Nov 2015.